As millions of individuals take GLP-1 medications like Ozempic and Wegovy, understanding how to safely fast for Yom Kippur becomes essential. While most can participate in fasting, precautions and planning are necessary to mitigate risks associated with these medications, partic…
A recent study from NYU Langone Health indicates that men genetically predisposed to androgenetic alopecia may face a 7% increased risk of hair loss when using GLP-1 drugs such as…
A recent study presented at the 2026 European Respiratory Society Congress indicates that semaglutide, a medication primarily used for diabetes and weight loss, may significantly…
A recent NIH-funded study indicates that semaglutide, a key ingredient in GLP-1 drugs like Ozempic, may extend lifespan and improve various health markers in older mice. The resea…
A recent review published in the International Journal of Molecular Sciences examines over 126 studies on berberine, highlighting its effects on gut inflammation, the intestinal b…
Recent research indicates that semaglutide, a medication commonly used for type 2 diabetes and weight management, may also reduce asthma attacks by nearly 40% and COPD flare-ups b…
Ana Navarro, a political commentator and guest host on The View, revealed her weight loss journey during the show's 30th anniversary season debut. She humorously credited her sign…
A recent study indicates that semaglutide, a GLP-1 drug commonly used for weight loss, may extend lifespan and improve health markers in elderly mice, mimicking the effects of cal…
Recent studies indicate that GLP-1 obesity injections, including Ozempic and Mounjaro, may not be effective for all individuals, with some participants failing to achieve signific…
A recent review in JAMA Otolaryngology highlights the potential benefits of GLP-1 weight-loss drugs, such as tirzepatide, in reducing the severity of obesity-related sleep apnea.…
A recent review published in the International Journal of Molecular Sciences examines the effects of berberine on metabolism, revealing that its impact is more nuanced than often…
A recent study published in the Journal of Investigative Dermatology suggests that GLP-1 drugs, commonly used for weight loss and diabetes management, may increase the risk of hai…
The beauty industry is rapidly evolving in response to the adoption of GLP-1 weight-loss drugs, creating a new market for beauty products that promise to counteract the side effec…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…